Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
344 studies found for:    Open Studies | "Uterine Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus
Conditions: Complex Endometrial Hyperplasia With Atypia;   Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions: Drug: Levonorgestrel;   Drug: Metformin
22 Not yet recruiting Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines
Condition: Endometrial Adenocarcinoma
Interventions: Drug: Ketamine;   Drug: dexmedetomidine;   Drug: bupivacaine
23 Not yet recruiting Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy
Condition: Endometrial Polyps
Interventions: Procedure: Hysteroscopic morcellation;   Procedure: Standard hysteroscopic resection
24 Recruiting A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women
Condition: Adenocarcinoma of the Endometrium
Intervention: Drug: Metformin
25 Not yet recruiting Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Conditions: Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Study of Socioeconomic and Demographic Variables
26 Not yet recruiting Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: Recurrent Uterine Corpus Carcinoma;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
27 Not yet recruiting Natural Supplements and a Special Diet in Eliminating Cancer-impacting Hormones From Sources Outside the Body in Patients With Early-Stage or Remission Prostate Cancer, Breast Cancer, or Uterine Cancer
Conditions: Breast Cancer;   Prostate Cancer;   Sarcoma
Interventions: Other: laboratory biomarker analysis;   Procedure: therapeutic dietary intervention
28 Recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulvar Cancer;   Bladder Cancer
Intervention: Device: Image-Guided Brachytherapy
29 Recruiting Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Conditions: Breast Cancer;   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Uterine Cancer;   Cervical Cancer;   Endometrial Cancer
Interventions: Biological: Vigil;   Drug: Durvalumab
30 Recruiting MR-HIFU for Recurrent Gynaecological Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Uterine Cancer;   Ovarian Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Device: Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU)
31 Not yet recruiting Pembro/Carbo/Taxol in Endometrial Cancer
Conditions: Endometrial Cancer;   Endometrial Adenocarcinoma
Interventions: Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: Carboplatin
32 Recruiting Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Condition: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
Intervention: Radiation: Radiotherapy
33 Recruiting Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
Conditions: Endometrial Atypical Hyperplasia;   Endometrial Adenocarcinoma
Interventions: Drug: Megestrol acetate and metformin;   Drug: Megestrol acetate
34 Not yet recruiting Prognostic Biomarkers in Patients With Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
35 Not yet recruiting Biomarkers in Samples From Patients With Endometrial Cancer
Conditions: Lynch Syndrome;   Recurrent Uterine Corpus Carcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
36 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Internal Radiation Therapy;   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis
37 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
38 Recruiting Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Lung Cancer;   Melanoma;   Non-Hodgkin's Lymphoma;   Uterine Cancer;   CORPUS UTERI,ENDOMETRIUM;   LUNG;   OVARY
Intervention:
39 Recruiting Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Conditions: Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
Intervention:
40 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.